Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Effect of Preoperative Intravenous Pantoprazole in Elective-Surgery Patients: A Pilot Study DIGESTIVE DISEASES AND SCIENCES Pisegna, J. R., Karlstadt, R. G., Norton, J. A., Fogel, R., Oh, D. S., Graepel, G. J., Dorr, M. B. 2009; 54 (5): 1041-1049

Abstract

This study evaluated the effects of intravenous pantoprazole on gastric volume and acid output in elective-surgical patients.This is a multicenter, randomized, pilot study of adult patients receiving intravenous pantoprazole: 40 mg every 24 h, 40 mg every 12 h (q12h) or 80 mg q12h. The first dose was administered 1 h before general anesthesia for surgery. All gastric fluid was aspirated through a nasogastric tube 1 h before dosing and through the postoperative period. Aspirate volume was recorded; pH and H(+) concentrations were measured.Twenty-six patients were enrolled and 21 were evaluable. Pantoprazole was well tolerated. All regimens decreased gastric acid output and volume, and increased pH within 1 h of dosing. Effects were sustained for up to 12 h following single-dose administration.Intravenous pantoprazole administered prior to anesthesia induction may be efficacious for the reduction of gastric volume and acid output, and for pulmonary aspiration prophylaxis in surgical patients.

View details for DOI 10.1007/s10620-008-0445-1

View details for Web of Science ID 000264810100018

View details for PubMedID 18754096